Funding Round
Omniscient raises $15M strategic investment from Stryker Neurovascular
Stryker Corporate News4/3/2026·04/03/26🌐 Asia
Summary
Omniscient Neurotechnology received a $15M strategic investment from Stryker Neurovascular as part of a commercial partnership agreement. Stryker will integrate Omniscient's qEEG connectome mapping into their neurosurgical planning workflow and co-market the combined solution to Stryker's 3,000+ global neurosurgical center customer base.
Why it matters
Stryker Neurovascular partnering with Omniscient gives their AI neuroimaging platform immediate access to the world's largest neurosurgical commercial infrastructure. This type of strategic investment from a market leader typically precedes an acquisition — Omniscient investors should note the exit optionality.
#AI Diagnostics#Industry#Neuroimaging#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in